Pharma at war with Azar?

  • After reporting a 45% increase in quarterly profit Pfizer said “it’s business as normal”.
  • Drug companies have made clear that they’ll never voluntarily reduce prices.
  • The pharma industry has spent more than $216 million on lobbying this year.
  • “Telling companies to voluntarily lower their prices and expecting it to happen on a consistent basis is not a realistic long-term policy proposition,” said Anthony T. LoSasso, a professor of health policy and administration at the University of Illinois at Chicago.

Business as normal — three words that mean drug companies don’t care what you think of their behavior.  Pfizer’s CEO fired the first shots this week with the Trump administration directly in the center of their target.

Let’s put this in context.  More than half of Americans (54 percent) have delayed medical care for themselves in the past 12 months because they could not afford it.  In addition:

Can you say Medicare for all?
To ignore the prevailing attitude towards the costs of prescription drugs says two things:
1ne: We don’t give a damn what the public wants/thinks.
2wo: Wall Street is our primary customer.
So sad….

Leave a Reply

Your email address will not be published. Required fields are marked *